Literature DB >> 15288318

In vitro antagonism between beta-lactam and macrolide in Streptococcus pneumoniae: how important is the antibiotic order?

Mar Ortega1, Francesc Marco, Alex Soriano, Julià Gómez, Manel Almela, Josep Mensa.   

Abstract

We found that the in vitro interaction between penicillin or cefotaxime and erythromycin against Streptococcus pneumoniae varies depending on the order of antibiotic exposure. Time-kill experiments were performed with penicillin, cefotaxime, erythromycin and different order combinations of both beta-lactams with erythromycin. The mean difference between the colony count at 0 and 6h for penicillin, cefotaxime and erythromycin tested separately was 3.5 log cfu/mL, 2.4 and 1.5 respectively for susceptible strains. The mean difference for the combination of beta-lactam and erythromycin studied simultaneously was 1.8 log cfu/mL for these strains. The association of penicillin or cefotaxime with erythromycin added two hours later showed an activity similar to those of beta-lactam alone (mean difference was 3.0 for this association with penicillin and 2.5 with cefotaxime). Therefore, the antagonistic effect of macrolide activity could be less important if erythromycin was administrated after beta-lactam.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288318     DOI: 10.1016/j.ijantimicag.2004.02.030

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  3 in total

1.  Macrolide use in the treatment of critically ill patients with pneumonia: Incidence, correlates, timing and outcomes.

Authors:  Wendy I Sligl; Holly Hoang; Dean T Eurich; Atul Malhotra; Thomas J Marrie; Sumit R Majumdar
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

2.  Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.

Authors:  E García Vázquez; J Mensa; J A Martínez; M A Marcos; J Puig; M Ortega; A Torres
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-03       Impact factor: 3.267

3.  Revising the role of the pneumococcal vex-vncRS locus in vancomycin tolerance.

Authors:  Wolfgang Haas; Jack Sublett; Deepak Kaushal; Elaine I Tuomanen
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.